YA
Therapeutic Areas
OmniAb Pipeline
| Drug | Indication | Phase |
|---|---|---|
| JNJ-81201887 (via Janssen) | Plaque Psoriasis | Approved |
| LN-144 (via Iovance) | Advanced Melanoma | BLA Submitted |
| Multiple Partner Programs | Various (Oncology, Immunology, etc.) | Phase I to Phase III |
| Drug | Indication | Phase |
|---|---|---|
| JNJ-81201887 (via Janssen) | Plaque Psoriasis | Approved |
| LN-144 (via Iovance) | Advanced Melanoma | BLA Submitted |
| Multiple Partner Programs | Various (Oncology, Immunology, etc.) | Phase I to Phase III |